| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 404 |
| 1 | ASPIRIN | 298 |
| 2 | ASPIRIN 325 MG | 282 |
| 3 | ASPIRIN 81 MG | 282 |
| 4 | APIXABAN | 210 |
| 5 | CLOPIDOGREL | 183 |
| 6 | WARFARIN | 176 |
| 7 | CLOPIDOGREL BISULFATE | 150 |
| 8 | FUROSEMIDE | 134 |
| 9 | DABIGATRAN ETEXILATE | 129 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBUPROFEN LYSINE | 34 | 0.0598 |
| 1 | DIAZEPAM INTENSOL | 1 | 0.0333 |
| 2 | FACTOR XIII CONCENTRATE (HUMAN) | 3 | 0.0330 |
| 3 | ASPIRIN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE | 1 | 0.0323 |
| 4 | ANDEXANET ALFA | 18 | 0.0254 |
| 5 | PHENOBARBITAL SODIUM | 9 | 0.0216 |
| 6 | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | 6 | 0.0187 |
| 7 | BROMPHENIRAMINE MALEATE | 6 | 0.0168 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE | 6 | 0.0167 |
| 9 | PORACTANT ALFA | 8 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 608 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 466 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 314 |
| 3 | Corticosteroid [EPC] | 166 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 155 |
| 5 | Loop Diuretic [EPC] | 150 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 124 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 99 |
| 8 | beta-Adrenergic Blocker [EPC] | 89 |
| 9 | Benzodiazepine [EPC] | 88 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 11 | 0.0095 |
| 1 | Protease Activator [EPC] | 1 | 0.0078 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 6 | 0.0042 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 4 | Factor Xa Inhibitor [EPC] | 608 | 0.0022 |
| 5 | Lipid Emulsion [EPC] | 5 | 0.0019 |
| 6 | Monobactam Antibacterial [EPC] | 5 | 0.0018 |
| 7 | Osmotic Diuretic [EPC] | 9 | 0.0017 |
| 8 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 9 | Diagnostic Dye [EPC] | 1 | 0.0015 |